Connection

John Gnann to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications John Gnann has written about Cost-Benefit Analysis.
John Gnann
Connection Strength
0.005
Cost-Benefit Analysis
  1. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.